KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-Current Debt (2018 - 2025)

Historic Non-Current Debt for Twist Bioscience (TWST) over the last 5 years, with Q4 2025 value amounting to $15.0 million.

  • Twist Bioscience's Non-Current Debt changed 0.0% to $15.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $15.0 million for FY2025, which is N/A changed from last year.
  • Twist Bioscience's Non-Current Debt amounted to $15.0 million in Q4 2025, which was down 0.0% from $15.0 million recorded in Q3 2025.
  • Twist Bioscience's Non-Current Debt's 5-year high stood at $15.0 million during Q4 2024, with a 5-year trough of $15.0 million in Q4 2024.